is bpc 157 good for the liver toxicity Pentadecapeptide and its effects on a NSAID model: Diclofenac-induced gastrointestinal, liver, and encephalopathy lesions BPC-157 & Liver: Safety, Enzymes, – BPC-157 Peptide: Proven Research Guide – Protective Effects of BPC 157

they can re-dissolve in body fluids and reenter circulation, or may be "shed" from the tissue

Jackson AA (2002)

Hypokalemia: Rapid treatment of severe anaemia with vitamin B12 could cause low potassium levels (hypokalemia), necessitating monitoring

Never substitute one diluent for another on your own

Ongoing peptide research focuses on managing cancers, dementia, diabetes, and heart disease

A Phase I safety study and a Phase II ulcerative colitis trial of the BPC-157 formulation PL 14736 were conducted by the Croatian pharmaceutical company Pliva, but full peer-reviewed Phase II efficacy results have not been published